Dr. Christopher Toomey, MD, PhD

Dr. Toomey practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Toomey's NPI, 1578922092, was assigned on February 11, 2016. Dr. Toomey graduated from Duke University School Of Medicine in 2016. Dr. Toomey holds California license A151210.

Dr. Toomey's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Toomey's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Toomey is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toomey practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Toomey's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Toomey is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Toomey's licenses on file in 2 states: California and Maryland.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, hypertensive retinopathy, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Toomey treats.

CMS data shows 3,989 Medicare services from Dr. Toomey across 8 procedure codes in 2024, for 185 Medicare patients. Medicare paid $140,948 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Toomey in 2024. The largest group is 75 to 84, with 75 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toomey's median patient age at 67, with 49% women.

In 2024, Dr. Toomey wrote 84 Medicare Part D claims for 33 patients. 38% of them were for generic drugs. CMS names the drug for 40 of them, across 3 drugs with 11 or more claims each, at $1,128 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Toomey for performance year 2024, reported as part of a group. Dr. Toomey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 40 papers to Dr. Toomey, published from 2010 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Macular Degeneration, Autoimmune Diseases and Autoimmunity. Dr. Toomey has published most often in Retina. Dr. Toomey's most frequent co-authors are William R. Freeman, MD, Michael Henry Goldbaum, MD and Evan Walker.

CMS Open Payments shows 21 general payments to Dr. Toomey from 9 drug and device companies from 2017 to 2025. Grants make up the largest share, 97% of the total. Alcon Research Ltd paid the most, $75,000.

Dr. Toomey graduated from Duke University School Of Medicine in 2016.

Dr. Toomey is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.